These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22123369

  • 21. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K, Cicutti N, Maurin A, Guez D, Schiavi P.
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [Abstract] [Full Text] [Related]

  • 22. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K, Kobayashi N, Ohno T, Fukushima H, Matsuoka H.
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [Abstract] [Full Text] [Related]

  • 23. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
    Janczak-Bazan A.
    Ann Acad Med Stetin; 2006 Aug; 52(1):51-61; discussion 61-2. PubMed ID: 17131847
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.
    Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, Miwa T, Masuyama T.
    Circulation; 2004 May 04; 109(17):2143-9. PubMed ID: 15051632
    [Abstract] [Full Text] [Related]

  • 27. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, Izawa H, Nagata K, Yokota M.
    Clin Exp Pharmacol Physiol; 2006 Dec 04; 33(12):1164-71. PubMed ID: 17184496
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive effect of perindopril: experimental pharmacology.
    Barthelmebs M, Devissaguet M, Imbs JL.
    Clin Exp Hypertens A; 1989 Dec 04; 11 Suppl 2():471-86. PubMed ID: 2691126
    [Abstract] [Full Text] [Related]

  • 29. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R, Pasanisi G, Notarstefano P, Campo G, Gardini E, Ceconi C.
    Am J Hypertens; 2005 Sep 04; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [Abstract] [Full Text] [Related]

  • 30. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
    Dinicolantonio JJ, Lavie CJ, O'Keefe JH.
    Postgrad Med; 2013 Jul 04; 125(4):154-68. PubMed ID: 23933903
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M, Sakata Y, Mano T, Yoshida J, Ohtani T, Takeda Y, Miwa T, Masuyama T, Yamamoto K, Hori M.
    J Hypertens; 2007 Feb 04; 25(2):455-61. PubMed ID: 17211254
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M.
    Can J Cardiol; 1999 May 04; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.
    Nishizawa T, Cheng XW, Jin Z, Obata K, Nagata K, Hirashiki A, Sasaki T, Noda A, Takeshita K, Izawa H, Shi GP, Kuzuya M, Okumura K, Murohara T.
    J Hypertens; 2010 Jul 04; 28(7):1515-26. PubMed ID: 20543715
    [Abstract] [Full Text] [Related]

  • 35. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.
    Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI.
    Circ Res; 2001 Oct 12; 89(8):678-83. PubMed ID: 11597990
    [Abstract] [Full Text] [Related]

  • 36. Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
    Black MJ, Bertram JF, Johnston CI.
    J Hypertens; 2001 Apr 12; 19(4):785-94. PubMed ID: 11330882
    [Abstract] [Full Text] [Related]

  • 37. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension.
    Hayakawa H, Raij L.
    Hypertension; 1997 Jan 12; 29(1 Pt 2):235-41. PubMed ID: 9039108
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats.
    Takeshita S, Tomiyama H, Yokoyama N, Kawamura Y, Furukawa T, Ishigai Y, Shibano T, Isshiki T, Sato T.
    Cardiovasc Res; 2001 Nov 12; 52(2):314-20. PubMed ID: 11684080
    [Abstract] [Full Text] [Related]

  • 39. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
    Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T.
    J Cardiovasc Pharmacol; 1994 Sep 12; 24(3):462-9. PubMed ID: 7528303
    [Abstract] [Full Text] [Related]

  • 40. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL, Mendelsohn FA, Ohishi M.
    Hypertension; 2002 Feb 12; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.